Lv71
4750 积分 2020-07-11 加入
Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
6小时前
求助中
Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial
2天前
已完结
A primer on clinical trial design
11天前
已完结
Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis
21天前
已完结
An indirect treatment comparison of tirzepatide 10 and 15 mg versus high-dose semaglutide 7.2 mg in people with obesity and type 2 diabetes
26天前
已完结
Comparative Efficacy of Tirzepatide, Liraglutide, and Semaglutide in Reduction of Risk of Major Adverse Cardiovascular Events in Patients with Obstructive Sleep Apnoea and Type 2 Diabetes: Real-world Evidence
1个月前
已完结
European society of endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause
1个月前
已完结
GLP-1 Receptor Signaling Has Different Effects on the Perikarya and Axons of the Hypophysiotropic Thyrotropin-Releasing Hormone Synthesizing Neurons in Male Mice
1个月前
已完结
Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward
1个月前
已完结
Studies Find Low Risk of Thyroid Cancer With GLP-1 Drugs for Diabetes
1个月前
已完结
皖公网安备34019202002308
